Codexis (CDXS) Other Non-Current Liabilities (2010 - 2026)
Codexis (CDXS) recorded quarterly Other Non-Current Liabilities of $1.3 million in Q1 2026, up 0.6% quarter-over-quarter from $1.3 million in Q4 2025, and up 4.05% on a YoY basis from $1.3 million in Q1 2025.
Codexis (CDXS) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Codexis' Other Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities rose 4.05% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (up 4.05% YoY), while the FY2025 annual figure was $1.3 million, up 4.65% from the prior year.
- Other Non-Current Liabilities was $1.3 million for Q1 2026 at Codexis, up from $1.3 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $1.4 million in Q2 2023 to a low of $1.2 million in Q3 2023.
- Historically, Other Non-Current Liabilities has averaged $1.3 million across 5 years, with a median of $1.3 million in 2025.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities climbed 29.02% in 2022, then slipped 10.1% in 2023.
- A 5-year view of Other Non-Current Liabilities shows it stood at $1.4 million in 2022, then declined by 10.07% to $1.2 million in 2023, then advanced by 2.84% to $1.3 million in 2024, then increased by 4.65% to $1.3 million in 2025, then gained by 0.6% to $1.3 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $1.3 million (Q1 2026), $1.3 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.34 Mn |
| Dec 31, 2025 | 1.33 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Mar 31, 2025 | 1.28 Mn |
| Dec 31, 2024 | 1.27 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Mar 31, 2024 | 1.25 Mn |
| Dec 31, 2023 | 1.23 Mn |
| Sep 30, 2023 | 1.22 Mn |
| Jun 30, 2023 | 1.41 Mn |
| Mar 31, 2023 | 1.39 Mn |
| Dec 31, 2022 | 1.37 Mn |
| Sep 30, 2022 | 1.36 Mn |
| Jun 30, 2022 | 1.34 Mn |
| Mar 31, 2022 | 1.33 Mn |
| Dec 31, 2021 | 1.31 Mn |
| Sep 30, 2021 | 1.05 Mn |
| Jun 30, 2021 | 1.29 Mn |